Research Management Group (RMG)

American Diabetes Association (ADA)
Pathway to Stop Diabetes
Initiator Award (postdoc-to-faculty transition award)

$1.625M limited ADA Pathway to Stop Diabetes Initiator Award"-- postdoctoral fellow -to-faculty transition award. An internal selection process is required.


The 2018 internal deadline has passed. This webpage is for your reference only.


This is one of three related limited ADA Pathway to Stop Diabetes Awards.
The other two programs are:  


# of applicants: 1 (Stanford is permitted ONE total nomination. It can be either an "Initiator", an "Accelerator", or a "Visionary Award" applicant.)


Internal deadline: Tuesday, April 3, 2018, 5 p.m.(see the internal submission guidelines below)
For applicant selected:
Institutional representative (RPM/RMG) deadline: June 25, 2018
Sponsor deadline: July 2, 2018
Start date for funding: Jan. 1, 2019

The sponsor's guidelines can be downloaded from this webpage.
However, please see the eligibility section and internal submission guidelines below.

Amount of funding:
Awards provide two distinct phases of research support:
Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs),
Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Combined support for Phase 1 and Phase 2 can total up to $1,625,000 for up to 7 years


The Initiator awards are designed to support early career researchers who have distinguished themselves during their research training as exceptionally talented and promising research investigators with a high likelihood of establishing successful, independent research programs and making seminal contributions in diabetes research. These awards provide salary and research support for applicants during late stages of mentored training through establishment as independent research faculty.

Research Topics:
The Pathway to Stop Diabetes Research Program will consider applications directed toward all topics rele-vant to prevention, treatment and cure of all types of diabetes (type 1, type 2, and gestational diabetes), diabetes-related disease states (obesity, pre-diabetes, and other insulin resistant states) and the complications of the disease. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics and physics.

Research type:
You will need to indicate whether the proposed research basic, clinical, or translational. For the purpose of this award, clinical research is defined as research directly involving humans, and includes educational, psychosocial, behavioral, epidemiologic, and health services research as well as clinical studies of normal physiology and mechanisms of disease. Translational research is defined as research that accelerates the transition of scientific discoveries into clinical applications, by efficiently advancing knowledge of efficacy to the next level of clinical application.

Review Criteria
Scientific excellence is the primary benchmark to be evaluated for all Pathway applications, with an emphasis on the investigator’s potential to significantly impact the field of diabetes research. The proposed research strategy serves as a reflection of the individual’s capacity for innovation, creativity and collaboration. The review will include the following components:

Principal Investigator

Research Strategy


By Tuesday, April 3, 2018, 5 p.m, please submit one PDF file containing the following in the order listed below to:

Jeanne Heschele
Research Management Group (RMG)

File name: Last name_ADA_Initiator.pdf

Postdocs: You do not have to prepare a budget, or submit a PDRF form or submit your internal proposals through your RPM or the RMG Fellowship office. You can submit them directly to Jeanne.

1) Title Page
American Diabetes Association Pathway to Stop Diabetes "Initiator Award"
Project Title:
Indicate Diabetes Category: both Type 1 and Type 2 Diabetes; Type 1 Diabetes, Type 2 diabetes, Gestational Diabetes, Obesity, Pre-diabetes/insulin resistance
Research type: Basic, clinical, or translational
PI name, appointment, Department, address, phone, email


2) Nomination letter printed on your department or division's letterhead, prepared by your mentor and co-signed by your Division Chief or your Department Chair addressed to Dr. Peter Sarnow and the School of Medicine Awards Committee members. (These guidelines are based on the sponsor's requirement.)
Provide rationale for institution’s nomination of candidate, including why candidate is uniquely suited for the award.
Certify that the candidate has the appropriate full-time position at the sponsoring institution as required by the award.
Outline the candidate’s responsibilities and ensure that at least 75% of the nominee’s total time and effort will be allocated to research during the term of this award.
Provide assurance of an academic commitment to the candidate and to the research proposal.
Outline the institution’s plans to support the long-term development of the candidate, including specific expectations for the individual’s career course.


3) "Research Strategy" Proposal- up to 4 page maximum
Figures are allowed, but must be included in the 4 page limit.
References may be included, but may not exceed 1 page and are not included in 4 page limit.
(Formatting: Font size 11 or larger, Ariel or Helvetica font, single-spaced margins at least one-half inch.
The research strategy should provide a high level description of your scientific question(s) and the strategy(ies) and approach(es) that you will employ to address this question. It should be written with a level of detail appropriate for reviewers who are knowledgeable of the field, but who may not be directly involved in the proposed area of research. The Research strategy should not include a detailed project plan/methodology, and no preliminary data section is required.
The research strategy should address the following components:
a) Scientific question(s)/specific problem(s) to be addressed
b) Specific approach(es) that will be employed
c) Significance and potential impact of the work
d) The potential risks and challenges, and how they will be overcome


4) NIH Biosketch:
You can download instructions and a Word document of NIH biosketch from this webpage:


5) Other support-current and pending (name of sponsor, term, amount of funding)


Selection process
Your proposal will be reviewed by the School of Medicine Awards committee. That committee will select the ADA Pathway applicant to represent Stanford. Either an "Accelerator", "Innovator" or "Visionary" applicant.

Footer Links: